Taken together, these results demonstrated that NaBu may suppress Ang II‐induced cardiac hypertrophy through COX2 signalling pathway by inhibiting the activation of HDAC5/HDAC6. The gene discussed is HDAC6; the disease is cardiac hypertrophy.